Equities

Medical Marijuana Inc

MJNA:PKC

Medical Marijuana Inc

Actions
  • Price (USD)0.0019
  • Today's Change0.00 / 0.00%
  • Shares traded4.41m
  • 1 Year change-48.65%
  • Beta1.1503
Data delayed at least 15 minutes, as of May 31 2024 20:58 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Medical Marijuana, Inc. manufactures and distributes natural health, beauty and hemp-derived cannabidiol (CBD) products through e-commerce, direct sales, retail and wholesale distribution channels. It operates in three divisions. Medical Marijuana, Inc. division operates its Website to maintain an online presence, provide corporate, investor relations and educational information and news relating to it and the cannabis industry. HempMeds division distributes products directly in the United States and through its subsidiaries internationally primarily in Mexico and Brazil. The division's product is Real Scientific Hemp Oil (RSHO). RSHO is a full spectrum, complete CBD hemp oil, which contains the natural hemp oil in the industry. RSHO is offered in three varieties: Green, Blue and Gold. Kannaway is its direct selling division, which sells its CBD products in United States, Europe and Asia. Its product also includes Focus, which contains Nootropics that helps support cognitive function.

  • Revenue in USD (TTM)--
  • Net income in USD--
  • Incorporated2005
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Coeptis Therapeutics Holdings Inc0.00-16.31m10.04m5.00--2.26-----0.5804-0.58040.000.11970.00----0.00-212.70-36.90-378.58-37.81------------0.349------43.40------
Psyence Biomedical Ltd0.001.52m10.04m------6.63---0.0442-0.04420.00-0.39790.00------1.13--1.20-----------------------2.63------
Eterna Therapeutics Inc115.00k-22.92m10.28m8.00------89.39-4.25-4.250.0214-0.63070.0036--0.230514,375.00-70.71-169.05-88.77-223.00-114.78---19,912.17-682.61---15.551.64-----68.8911.84---58.86--
Universe Pharmaceuticals Inc32.31m-6.16m10.66m225.00--0.268--0.3299-1.70-1.708.9110.910.57277.932.50143,594.40-10.925.31-14.347.0731.9346.26-19.086.252.43-28.050.12180.00-19.522.5329.46---21.17--
Monopar Therapeutics Inc0.00-7.61m10.68m10.00--1.43-----0.5289-0.52890.000.42770.00----0.00-73.36-54.07-92.67-60.60------------0.00------20.10------
Scorpius Holdings Inc9.74m-32.20m10.73m82.00--0.1399--1.10-1.22-1.400.36630.79370.1372--26.56118,815.70-47.81-39.37-58.20-43.1868.56---348.43-1,068.210.2641-198.180.3179--1,789.583.841.96--27.32--
Vaccinex Inc124.00k-19.19m10.74m37.00--7.57--86.63-46.02-46.020.16851.680.0202--0.08943,351.35-312.93-262.29-731.45-------15,472.58-4,257.17---55.900.03--107.27-4.67-2.20---22.20--
Medical Marijuana Inc-100.00bn-100.00bn10.80m----0.0999----------0.019-----------22.66---23.11--70.58---145.521.79--0.0479--26.3039.07141.59---0.016--
Allarity Therapeutics Inc0.00-20.94m10.85m5.00---------599.34-599.340.00-18.880.00----0.00-100.46--------------------------3.02------
Ayala Pharmaceuticals Inc13.00k-48.07m10.91m20.00------839.55-7.46-7.460.0022-2.06------650.00--------0.00---369,784.60-----2.31----------------
Bon Natural Life Ltd29.52m4.60m10.92m96.000.55110.0911.980.36994.994.9932.1030.230.704515.275.19307,524.6010.8614.0413.6920.6829.9430.0015.4217.622.4130.540.09550.00-1.2922.32-26.3283.09-6.70--
Moleculin Biotech Inc0.00-26.82m11.03m18.00--0.5108-----12.94-12.940.009.340.00----0.00-65.50-46.84-75.07-51.49------------0.00-------2.56---21.54--
CV Sciences Inc15.86m-3.23m11.10m42.00--4.70--0.6999-0.0207-0.02070.10120.01451.591.4227.25377,571.40-32.43-43.42-83.71-77.7545.1351.81-20.38-45.680.2677-13.320.0472---1.24-19.80133.96-20.87----
Data as of May 31 2024. Currency figures normalised to Medical Marijuana Inc's reporting currency: US Dollar USD

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Private Asset Management, Inc.as of 30 Sep 202311.10k0.00%
Rothschild Investment Corp.as of 30 Sep 202310.00k0.00%
Vermillion & White Wealth Management Group LLCas of 31 Mar 20241.27k0.00%
Huntington National Bank (Investment Management)as of 31 Mar 20241.00k0.00%
Harmony Asset Management LLCas of 31 Mar 20240.000.00%
Gunn & Co. Investment Management, Inc.as of 31 Mar 20240.000.00%
Private Ocean LLCas of 31 Mar 20240.000.00%
Chas. P. Smith & Associates, PA, CPAsas of 31 Mar 20240.000.00%
More ▼
Data from 30 Sep 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.